Using the Absolute Advantage Coefficient (AAC) to Measure the Strength of Damage Hit by COVID-19 in India on a Growth-share Matrix
Overview
Affiliations
Background: The COVID-19 pandemic occurred and rapidly spread around the world. Some online dashboards have included essential features on a world map. However, only transforming data into visualizations for countries/regions is insufficient for the public need. This study aims to (1) develop an algorithm for classifying countries/regions into four quadrants inn GSM and (2) design an app for a better understanding of the COVID-19 situation.
Methods: We downloaded COVID-19 outbreak numbers daily from the Github website, including 189 countries/regions. A four-quadrant diagram was applied to present the classification of each country/region using Google Maps run on dashboards. A novel presentation scheme was used to identify the most struck entities by observing (1) the multiply infection rate (MIR) and (2) the growth trend in the recent 7 days. Four clusters of the COVID-19 outbreak were dynamically classified. An app based on a dashboard aimed at public understanding of the outbreak types and visualizing of the COVID-19 pandemic with Google Maps run on dashboards. The absolute advantage coefficient (AAC) was used to measure the damage hit by COVID-19 referred to the next two countries severely hit by COVID-19.
Results: We found that the two hypotheses were supported: India (i) is in the increasing status as of April 28, 2021; (ii) has a substantially higher ACC(= 0.81 > 0.70), and (iii) has a substantially higher ACC(= 0.66 < 0.70) as of May 17, 2021.
Conclusion: Four clusters of the COVID-19 outbreak were dynamically classified online on an app making the public understand the outbreak types of COVID-19 pandemic shown on dashboards. The app with GSM and AAC is recommended for researchers in other disease outbreaks, not just limited to COVID-19.
Lin H, Chou W, Chien T, Yeh Y, Kuo S, Hsu S Medicine (Baltimore). 2024; 103(3):e36547.
PMID: 38241545 PMC: 10798733. DOI: 10.1097/MD.0000000000036547.
Ho S, Chow J, Chou W Medicine (Baltimore). 2024; 103(3):e36219.
PMID: 38241539 PMC: 10798765. DOI: 10.1097/MD.0000000000036219.
Ho S, Chien T, Chou W Medicine (Baltimore). 2023; 102(50):e34511.
PMID: 38115345 PMC: 10727539. DOI: 10.1097/MD.0000000000034511.
Chuang H, Ho S, Chou W, Tsai C Medicine (Baltimore). 2023; 102(48):e36475.
PMID: 38050200 PMC: 10695623. DOI: 10.1097/MD.0000000000036475.
Lai P, Chou W, Chien T, Lai F Medicine (Baltimore). 2023; 102(44):e34801.
PMID: 37933006 PMC: 10627629. DOI: 10.1097/MD.0000000000034801.